TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Belluscura PLC ( (GB:BELL) ) has provided an announcement.
Belluscura PLC announced the termination of a $1.5 million Loan Note agreement with Omaha Value, Inc due to non-receipt of funds, resulting in the cancellation of related warrants. The company is exploring strategic alternatives to maximize value for stakeholders, including a potential asset sale to a US medical device company. This potential sale, which involves key assets and intellectual property, is under a 15-day exclusivity period for due diligence. The company’s shares remain suspended as it continues funding discussions and delays the finalization of its 2024 Annual Report.
More about Belluscura PLC
Belluscura PLC is a UK-based medical device company specializing in the development of oxygen enrichment technology, catering to various industries and therapeutic applications.
Average Trading Volume: 5,462,662
Technical Sentiment Signal: Sell
Current Market Cap: £3.01M
For a thorough assessment of BELL stock, go to TipRanks’ Stock Analysis page.